Target Price | $56.81 |
Price | $59.65 |
Deviation | 4.76% |
Number of Estimates | 21 |
21 Analysts have issued a price target Monster Beverage 2026 . The average Monster Beverage target price is $56.81. This is 4.76% lower than the current stock price. The highest price target is $65.00 8.97% , the lowest is $40.00 32.94% . | |
A rating was issued by 26 analysts: 13 Analysts recommend Monster Beverage to buy, 11 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Monster Beverage stock has an average upside potential 2026 of 4.76% . Most analysts recommend the Monster Beverage stock at Purchase. |
21 Analysts have issued a sales forecast Monster Beverage 2025 . The average Monster Beverage sales estimate is $8.0b . This is 6.46% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $8.3b 11.13% , the lowest is $7.7b 3.17% .
This results in the following potential growth metrics:
2024 | $7.5b | 4.94% |
---|---|---|
2025 | $8.0b | 6.46% |
2026 | $8.6b | 7.44% |
2027 | $9.2b | 7.62% |
2028 | $10.0b | 8.89% |
17 Analysts have issued an Monster Beverage EBITDA forecast 2025. The average Monster Beverage EBITDA estimate is $2.4b . This is 19.46% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $2.8b 40.86% , the lowest is $2.3b 13.00% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $2.0b | 1.36% |
---|---|---|
2025 | $2.4b | 19.46% |
2026 | $2.6b | 8.81% |
2027 | $2.8b | 8.23% |
2028 | $3.0b | 6.30% |
2024 | 26.84% | 6.01% |
---|---|---|
2025 | 30.11% | 12.20% |
2026 | 30.50% | 1.30% |
2027 | 30.67% | 0.56% |
2028 | 29.94% | 2.38% |
11 Monster Beverage Analysts have issued a net profit forecast 2025. The average Monster Beverage net profit estimate is $1.8b . This is 23.89% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.9b 29.05% , the lowest is $1.7b 18.92% .
This results in the following potential growth metrics and future Net Margins:
2024 | $1.4b | 3.25% |
---|---|---|
2025 | $1.8b | 23.06% |
2026 | $2.0b | 10.80% |
2027 | $2.1b | 8.66% |
2028 | $2.4b | 11.68% |
2024 | 19.35% | 7.80% |
---|---|---|
2025 | 22.37% | 15.60% |
2026 | 23.07% | 3.13% |
2027 | 23.29% | 0.95% |
2028 | 23.89% | 2.58% |
11 Analysts have issued a Monster Beverage forecast for earnings per share. The average Monster Beverage EPS is $1.83 . This is 23.65% higher than earnings per share in the financial year 2024. The highest EPS forecast is $1.91 29.05% , the lowest is $1.76 18.92% .
This results in the following potential growth metrics and future valuations:
2024 | $1.49 | 3.25% |
---|---|---|
2025 | $1.83 | 22.82% |
2026 | $2.03 | 10.93% |
2027 | $2.21 | 8.87% |
2028 | $2.47 | 11.76% |
Current | 40.20 | 4.52% |
---|---|---|
2025 | 32.53 | 19.08% |
2026 | 29.36 | 9.74% |
2027 | 27.02 | 7.97% |
2028 | 24.19 | 10.47% |
Based on analysts' sales estimates for 2025, the Monster Beverage stock is valued at an EV/Sales of 7.14 and an P/S ratio of 7.28 .
This results in the following potential growth metrics and future valuations:
Current | 7.60 | 7.20% |
---|---|---|
2025 | 7.14 | 6.06% |
2026 | 6.65 | 6.92% |
2027 | 6.17 | 7.08% |
2028 | 5.67 | 8.16% |
Current | 7.75 | 10.33% |
---|---|---|
2025 | 7.28 | 6.07% |
2026 | 6.77 | 6.92% |
2027 | 6.29 | 7.08% |
2028 | 5.78 | 8.16% |
Monster Beverage...
Analyst | Rating | Action | Date |
---|---|---|---|
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Apr 02 2025 |
Citigroup |
Buy
➜
Buy
|
Unchanged | Feb 28 2025 |
Deutsche Bank |
Buy
➜
Buy
|
Unchanged | Feb 28 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Feb 28 2025 |
Needham |
Hold
➜
Hold
|
Unchanged | Feb 28 2025 |
JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Feb 12 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Jan 22 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Apr 02 2025 |
Unchanged
Citigroup:
Buy
➜
Buy
|
Feb 28 2025 |
Unchanged
Deutsche Bank:
Buy
➜
Buy
|
Feb 28 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Feb 28 2025 |
Unchanged
Needham:
Hold
➜
Hold
|
Feb 28 2025 |
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Feb 12 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Jan 22 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.